Net profit of Kilitch Drugs (India) rose 22.78% to Rs 2.91 crore in the quarter ended December 2023 as against Rs 2.37 crore during the previous quarter ended December 2022. Sales rose 6.07% to Rs 31.79 crore in the quarter ended December 2023 as against Rs 29.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales31.7929.97 6 OPM %7.1713.28 - PBDT3.643.38 8 PBT2.822.45 15 NP2.912.37 23 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) rose 95.06% to Rs 4.74 crore in the quarter ended September 2023 as against Rs 2.43 crore during the previous quarter ended September 2022. Sales rose 34.20% to Rs 41.20 crore in the quarter ended September 2023 as against Rs 30.70 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales41.2030.70 34 OPM %20.9212.87 - PBDT7.602.44 211 PBT6.781.55 337 NP4.742.43 95 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News

Kilitch Drugs (India) announced that the 31st Annual General Meeting (AGM) of the company will be held on 29 September 2023.Powered by Capital Market - Live News